Select Publications

Conference Presentations

Montgomery B; Joshua A; Gleave M; Fleshner N; Bubley G; True L; Tretiakova M; Wu K; Novotny W; Peterson A; Amelsberg A; Taplin ME, 2015, 'A randomized, open-label, phase 2 study of enzalutamide as neoadjuvant therapy for patients undergoing prostatectomy for localized prostate cancer', presented at European Cancer Congress 2015 / 18th Meeting of the European-Cancer-Organization (ECCO) / 40th Meeting of the European-Society-for-Medical-Oncology (ESMO), AUSTRIA, Vienna, 25 September 2015 - 29 September 2015, http://dx.doi.org/10.1016/S0959-8049(16)31323-5

Daud A; Ribas A; Robert C; Hodi FS; Wolchok JD; Joshua AM; Hwu W-J; Weber JS; Gangadhar TC; Joseph RW; Dronca RS; Patnaik A; Zarour HM; Kefford R; Lindia JA; Li XN; Ebbinghaus S; Kang SP; Hamid O, 2015, 'Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001.', Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036901915&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1


Back to profile page